Literature DB >> 2454210

Deficient axonal transport of substance P in streptozocin-induced diabetic rats. Effects of sorbinil and insulin.

D R Tomlinson1, J P Robinson, G B Willars, P Keen.   

Abstract

This study measured the accumulation of substance P-like immunoreactivity (SPLI) proximal and distal to 12-h constricting ligatures applied to rat sciatic nerves. There were three separate experiments, and the baseline for each consisted of control and age-matched rats with 3 wk of untreated streptozocin-induced diabetes. We compared the effects of twice-daily insulin treatment, daily sorbinil (25 mg.kg-1.day-1 p.o.), and a combination of both treatments. In untreated diabetic rats the anterograde accumulation of SPLI was reduced by 30-40%. This deficit was unaffected by sorbinil alone but was attenuated by insulin and prevented completely by insulin and sorbinil combined. There were also indications that diabetes caused reductions in retrograde accumulation of SPLI and its content in unconstricted nerve and the L4 dorsal root ganglion. The fraction of SPLI undergoing net anterograde or retrograde movement and the velocities of accumulation were unaffected by diabetes or the treatment regimens. These findings indicate a reduction in the amount of substance P moved by axonal transport in diabetic rats that is related partly to aldose reductase activity and partly to some other insulin-correctable consequence of experimental diabetes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454210     DOI: 10.2337/diab.37.4.488

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  6 in total

1.  Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats.

Authors:  D R Tomlinson; J P Robinson; A M Compton; P Keen
Journal:  Diabetologia       Date:  1989-09       Impact factor: 10.122

2.  Impaired induction of nerve ornithine decarboxylase activity in the streptozotocin-diabetic rat is prevented by the aldose reductase inhibitor ponalrestat.

Authors:  C Pekiner; W G McLean
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

3.  Functional magnetic resonance imaging of the spinal cord during sensory stimulation in diabetic rats.

Authors:  Krisztina L Malisza; Cheryl Jones; Marco L H Gruwel; Derek Foreman; Paul Fernyhough; Nigel A Calcutt
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

4.  Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice.

Authors:  Kristina K Beiswenger; Nigel A Calcutt; Andrew P Mizisin
Journal:  Neurosci Lett       Date:  2008-07-03       Impact factor: 3.046

5.  Effect of streptozotocin-induced diabetes mellitus on release of vasoactive intestinal polypeptide from rodent small intestine.

Authors:  T V Nowak; W W Chey; T M Chang; J P Weisbruch; G Fouquet
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

6.  Changes in sensory neuropeptides in dorsal root ganglion and spinal cord of spontaneously diabetic BB rats. A quantitative immunohistochemical study.

Authors:  G Terenghi; S Chen; A L Carrington; J M Polak; D R Tomlinson
Journal:  Acta Diabetol       Date:  1994-12       Impact factor: 4.280

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.